Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06507007

Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Gødstrup Hospital · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The goal of this case-control study is to pave the way for new revolutionary treatment measures within hearing loss that could either replace or delay the need for hearing aids. The study focuses on people with Turner syndrome (TS). The aim is to find out if there are specific DNA methylation patterns and/or RNA expression profiles linked to sensorineural hearing loss (SNHL) in people with TS. Additionally, the structure and function of the inner ear in these individuals will be examined to see if there is a connection to their epigenetic profile. The main question it aims to answer is: Does epigenetics constitute a common denominator for some of the unexplained SNHL cases? Turner Syndrome (TS) represents an ideal model for studying epigenetics related to sensorineural hearing loss (SNHL). Participants will undergo the following tests: * Ear examinations * Hearing tests * Balance tests * Blood tests * MRI scans * CBCT (cone-beam computed tomography) scans

Conditions

Timeline

Start date
2025-02-01
Primary completion
2026-06-30
Completion
2027-07-30
First posted
2024-07-18
Last updated
2026-01-27

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06507007. Inclusion in this directory is not an endorsement.

Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome (NCT06507007) · Clinical Trials Directory